Essential Alerts: New Zealand, Paraguay, and South Africa

This week's top three essential alerts include:
1. New Zealand: The Ministry of Health has revised guidelines for therapeutic product regulation, introducing new laws and standards for good clinical practice, enhanced safety reporting, and detailed considerations for early-stage trials.
2. Paraguay: Resolution number 226 of 2024 outlines requirements for registering, modifying, and renewing sanitary registrations for Class 2, 3, and 4 medical devices, as well as Class 1 devices. These changes will take effect on September 16, 2024.
3. South Africa: Amendments have been made to the application process for obtaining or renewing licenses under the Medicines and Related Substances Act, specifically affecting sections 22C and 22D.
Stay informed with RegDesk for further updates!